序号 |
标题 |
次数 |
作者 |
发布时间 |
86671 |
甲基丙烯酸丙炔基酯(PgMA) |
248 |
WYQ |
2024-11-21 |
86672 |
-丙炔基咔唑(PC)是一种有机化合物 |
195 |
WYQ |
2024-11-21 |
86673 |
1,4,7,10-四氮杂环十二烷-1,4,7-三(乙酸)-10(3-丁炔基乙酰胺) |
100 |
wyh |
2024-11-21 |
86674 |
7-(3'-哌啶基丙炔基)喜树碱(CPT21) |
93 |
WYQ |
2024-11-21 |
86675 |
双环肽螯合物DOTA-E「c(RGDyK)2」,DOTA标记序列多肽 |
155 |
zyl |
2024-11-21 |
86676 |
双功能螯合物DOTA-GGGA;149206-86-0 |
104 |
wyh |
2024-11-21 |
86677 |
二茂铁吡啶鎓和聚乙二醇的降冰片烯共聚物 , P-NB-Py-Fc-PEG |
119 |
kx |
2024-11-21 |
86678 |
碘丙炔基正丁胺甲酸酯(IPBC) |
135 |
WYQ |
2024-11-21 |
86679 |
炔丙基-甲基丙烯酸酯,也被称为甲基丙烯酸丙炔基酯 |
133 |
WYQ |
2024-11-21 |
86680 |
丙炔基功能化的L-谷氨酸酯-N-羧酸内酸酐(PPLG-NCA) |
102 |
WYQ |
2024-11-21 |
86681 |
gadolinium(3+),2-[4,7,10-tris(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate |
90 |
wyh |
2024-11-21 |
86682 |
丙炔基甘氨酸(PAG) |
150 |
WYQ |
2024-11-21 |
86683 |
5-碘甲基降冰片烯 , IMNB |
118 |
kx |
2024-11-21 |
86684 |
整合素DOTA-E-[cyclo(RGDfK(Acp))]2 |
95 |
zyl |
2024-11-21 |
86685 |
DOTA-E[CYCLO(RGDFK)]2探针多肽 |
119 |
wyh |
2024-11-21 |
86686 |
DOTA-JR-11,1039726-31-2,放射显影多肽 |
113 |
zyl |
2024-11-21 |
86687 |
5-降冰片烯-2-亚甲基环氧丙基醚 , NB-MGE |
103 |
kx |
2024-11-21 |
86688 |
DO3A-Thiol ;CAS:865470-67-3 DOTA-SH |
85 |
wyh |
2024-11-21 |
86689 |
七肽DOTA-VLASSAR,CAS号:1262403-90-6 |
98 |
zyl |
2024-11-21 |
86690 |
Gd-DOTA-HCBP的组成结构 |
113 |
wyh |
2024-11-21 |
86691 |
双阳离子中心咪唑功能化降冰片烯离子液体单体 , NB-O-Im+Br--Im+Br- |
139 |
kx |
2024-11-21 |
86692 |
479081-06-6 ;DOTA-(COOt-Bu)3-NHFmoc-Lys |
108 |
wyh |
2024-11-21 |
86693 |
DOTA-TATE,CAS:177943-89-4, DOTA-3-酪氨酰基-奥曲肽 |
111 |
zyl |
2024-11-21 |
86694 |
DOTA-octreotide的组成与结构 |
100 |
wyh |
2024-11-21 |
86695 |
endo-N-3,5-双三氟甲基联苯基降冰片烯酰亚胺, endo-PTNDI |
111 |
kx |
2024-11-21 |
86696 |
DOTA-Octreotide 大环配体奥曲肽 |
125 |
zyl |
2024-11-21 |
86697 |
端丙炔基聚乙二醇(PTPEG) |
156 |
WYQ |
2024-11-21 |
86698 |
CAS:127985-74-4,DOTA-p-NCS-Bn多肽标记的双功能螯合剂 |
108 |
wyh |
2024-11-21 |
86699 |
降冰片烯-异戊二烯共聚物 ,NBE-IP |
140 |
kx |
2024-11-21 |
86700 |
cyclo(RGDFK(DOTA))的特性与功能 |
99 |
wyh |
2024-11-21 |
86701 |
DOTA-cyclo(RGDfK) |
93 |
zyl |
2024-11-21 |
86702 |
Lu-DOTA-TATE;镥-大环配体-TATE多肽 |
364 |
wyh |
2024-11-21 |
86703 |
顺-5-降冰片烯-内型-2,3-二羧酸二乙酯 , endo-NDDE |
131 |
kx |
2024-11-21 |
86704 |
DOTA-NCS,DOTA-p-NCS-Bn,cas:127985-74-4 |
100 |
zyl |
2024-11-21 |
86705 |
DOTA-PEG-CPP;大环配体DOTA-聚乙二醇-酪蛋白磷酸肽 |
108 |
wyh |
2024-11-21 |
86706 |
Gd-DOTA-COOH 钆-四氮杂环配体-羧基 |
112 |
zyl |
2024-11-21 |
86707 |
DOTA-E「cyclo(RGDfK)2 |
99 |
wyh |
2024-11-21 |
86708 |
DOTA-(Tyr3)-Octreotate;大环配体修饰多肽 |
114 |
wyh |
2024-11-21 |
86709 |
单-6-(4-甲基丙烯酸丙炔基酯-1,2,3-三氮唑)-磺酸基-β-CD(PMA-sulfated-β-CD) |
113 |
WYQ |
2024-11-21 |
86710 |
碘丙炔基正丁氨基甲酸酯(IPBC) |
158 |
WYQ |
2024-11-21 |
86711 |
Gd-DOTA-多肽 |
88 |
zyl |
2024-11-21 |
86712 |
DSPE-PEG-DOTA ;二硬脂酰基磷脂酰乙醇胺- 聚乙二醇-大环化合物 |
283 |
wyh |
2024-11-21 |
86713 |
250612-06-7 ;DOTA-RGDfK dimer |
109 |
wyh |
2024-11-21 |
86714 |
DOTA-GA(tBu)4 cas306776-79-4 大环配体化合物 |
187 |
zyl |
2024-11-21 |
86715 |
250612-06-7 DOTA多肽探针二聚体 |
85 |
wyh |
2024-11-21 |